Combined inhaled salbutamol and mannitol therapy for mucus hyper-secretion in pulmonary diseases.
about
Fundamentals of aerosol therapy in critical careDry powder formulation of simvastatin.Identification of drugs that restore primary cilium expression in cancer cells.Nanocomposite microparticles (nCmP) for the delivery of tacrolimus in the treatment of pulmonary arterial hypertension.Synthesis and Characterization of Nanocomposite Microparticles (nCmP) for the Treatment of Cystic Fibrosis-Related InfectionsInhaled simvastatin nanoparticles for inflammatory lung disease.
P2860
Combined inhaled salbutamol and mannitol therapy for mucus hyper-secretion in pulmonary diseases.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Combined inhaled salbutamol an ...... cretion in pulmonary diseases.
@en
type
label
Combined inhaled salbutamol an ...... cretion in pulmonary diseases.
@en
prefLabel
Combined inhaled salbutamol an ...... cretion in pulmonary diseases.
@en
P2093
P2860
P50
P1433
P1476
Combined inhaled salbutamol an ...... cretion in pulmonary diseases.
@en
P2093
Giulia Ballerin
Lachlan Buddle
Paul M Young
Santo Scalia
P2860
P2888
P304
P356
10.1208/S12248-014-9560-4
P407
P577
2014-01-16T00:00:00Z
P5875
P6179
1027291198